Épisodes

  • Ep 43: A Conversation with Josh Kraft

    Ep 43: A Conversation with Josh Kraft
    Dec 16 2025

    Today’s “Prostate Cancer and You” podcast features Joshua Kraft, head of Kraft Family Philanthropies and former CEO of Boys & Girls Clubs of Boston. In this conversation with host Jordan Rich, Kraft discusses his experience with prostate cancer, sharing his journey from a PSA test to a Gleason score of 7. Kraft emphasizes the importance of early detection and treatment, as well as the significance of regular check-ups and the need for community awareness, particularly among men of color. He also discusses his family’s philanthropic legacy and his ongoing commitment to community service, including his role with the New England Patriots Foundation.

    Josh Kraft serves as president of the New England Patriots Foundation, where he oversees philanthropic support of education, health, social justice, diversity, and youth development. Josh has spent the majority of his career working in communities in and around Boston, starting with the Boys & Girls Club in Chelsea, which he founded in 1993 and went on to serve as executive director for 15 years.
    Afficher plus Afficher moins
    13 min
  • Ep 42: A Conversation with Dr. Adam Kibel

    Ep 42: A Conversation with Dr. Adam Kibel
    Sep 25 2025
    Today’s “Prostate Cancer and You” podcast features Dr. Adam Kibel is chair of the department of urology at Mass General Brigham. In this conversation with host Jordan Rich, Dr. Kibel discusses a clinical trial focused on using genetic data and MRI to improve early detection of prostate cancer. The trial, involving men aged 40-69, aims to identify high-risk individuals through genetic testing and targeted screening. Dr. Kibel discusses the importance of clinical trials as well as the promise of this particular study to improve detection, treatment, and even prevention of prostate cancer in the future. You can learn more about the study at https://rally.massgeneralbrigham.org/study/prostate_polygenic_risk_score. Dr. Adam S. Kibel is chair of urology at Mass General Brigham. In addition, he is the Elliott Carr Cutler Professor of Surgery at Harvard Medical Medicine and chairman of the Harvard Urology Residency Program. Dr. Kibel received his undergraduate and medical degrees from Cornell University, completed his urology residency at the Harvard Urology Program, and completed his fellowship at the Brady Urologic Institute at Johns Hopkins.
    Afficher plus Afficher moins
    18 min
  • Part II: Prostate Cancer Screening and Active Surveillance: A Conversation with Dr. Todd Cohen

    Part II: Prostate Cancer Screening and Active Surveillance: A Conversation with Dr. Todd Cohen
    Aug 26 2025
    In this second of a two-part podcast episode, Dr. Todd Cohen discusses the role of PSMA PET imaging in prostate cancer active surveillance, highlighting its potential to replace invasive biopsies. Cohen emphasizes the importance of communication and family involvement in active surveillance protocols. Advanced imaging technologies are evolving, offering hope for less invasive and more effective cancer management. Dr. Todd Cohen earned his MD from the University of Rochester and completed a Urology residency at the Cleveland Clinic, followed by a fellowship at Duke. He founded Piedmont Urology in Charlotte, NC, and co-founded Carolina Urology Partners, serving as CEO for nine years. He held leadership roles at Myriad Genetics and currently serves as VP of Medical Affairs at Blue Earth Diagnostics.
    Afficher plus Afficher moins
    12 min
  • Part I: Prostate Cancer Screening and Active Surveillance: A Conversation with Dr. Todd Cohen

    Part I: Prostate Cancer Screening and Active Surveillance: A Conversation with Dr. Todd Cohen
    Aug 26 2025
    In this first of a two-part podcast episode of “Prostate Cancer and You,” brought to you in part by Blue Earth Diagnostics, Dr. Todd Cohen, Blue Earth Diagnostics vice-president of medical affairs, discusses the practice of active surveillance in prostate cancer screening. Cohen explains the advancements in imaging, particularly PSMA PET scans, which have revolutionized prostate cancer detection. He also differentiates between active surveillance and watchful waiting, emphasizing the importance of individualized care and patient commitment in active surveillance. Dr. Todd Cohen earned his MD from the University of Rochester and completed a Urology residency at the Cleveland Clinic, followed by a fellowship at Duke. He founded Piedmont Urology in Charlotte, NC, and co-founded Carolina Urology Partners, serving as CEO for nine years. He held leadership roles at Myriad Genetics and currently serves as VP of Medical Affairs at Blue Earth Diagnostics.
    Afficher plus Afficher moins
    16 min
  • Ep 39 – Robotic Surgery’s Past, Present, and Future: A Conversation with Dr. Jean Joseph

    Ep 39 – Robotic Surgery’s Past, Present, and Future: A Conversation with Dr. Jean Joseph
    Jun 12 2025
    Today’s “Prostate Cancer and You” podcast features Dr. Jean Joseph, chairman of the department of urology at the University of Rochester Medical Center and keynote at the May 2025 MPCC Symposium. In this conversation with host Jordan Rich, Dr. Joseph furthers his keynote topics, discussing the history, benefits, and future development of robotic surgery for prostate cancer. The technology, initially developed for cardiac surgery, is less invasive than traditional surgery and has significantly reduced complications and side effects, allowing for a quicker recovery. Jean V. Joseph, MD, is W.W. Scott Professor and chairman of the department of urology at the University of Rochester Medical Center. He specializes in robotic surgery for urologic diseases, particularly prostate cancer. His research interests include surgical innovation, applications of novel robotic technology, and patient outcomes. Dr. Joseph completed a master class in laparoscopic prostatectomy at the Institute Mutualiste Montsouris (Paris, France) and holds a master’s in business administration from the Rochester Institute of Technology.
    Afficher plus Afficher moins
    11 min
  • Part II: Understanding Molecular Imaging and Radioligy and Therapy: What Every Patient Should Know

    Part II: Understanding Molecular Imaging and Radioligy and Therapy: What Every Patient Should Know
    Jun 4 2025
    In this second of a two-part podcast episode detailing new treatments for prostate cancer, Dr. Phillip Davis and Dr. Dan Stevens highlight the increasing accessibility of molecular imaging and radioligy and therapy across the US and the potential for earlier use of these technologies. They also discuss the promise of future advancements including personalized cancer treatments, the use of new radioactive isotopes, and the integration of AI in imaging and workflows. Both doctors stress the rapid developments in prostate cancer detection and treatment, encouraging patients to stay informed and involved in their care.
    Afficher plus Afficher moins
    12 min
  • Part I: Understanding Molecular Imaging and Radioligy and Therapy: What Every Patient Should Know

    Part I: Understanding Molecular Imaging and Radioligy and Therapy: What Every Patient Should Know
    Jun 4 2025
    In this first of a two-part podcast episode, Dr. Phillip Davis and Dr. Dan Stevens follow up on the symposium topic of “New Treatments for Prostate Cancer.” In Part I, Dr. Philip Davis explains molecular imaging, which uses a low dose of radioactive medicine to detect cancer and other diseases early, as well as providing doctors with both anatomic and functional information on the cancer cells. Dr. Dan Stevens details radioligy and therapy, which uses radioactive isotopes to target cancer cells more precisely than traditional radiation therapy. Both technologies offer improved treatment options, enhancing patient outcomes.
    Afficher plus Afficher moins
    13 min
  • A Conversation with Dr. Preston Sprenkle and cancer survivor Bob Palmer

    A Conversation with Dr. Preston Sprenkle and cancer survivor Bob Palmer
    Jan 15 2025
    Today’s podcast in the “Prostate Cancer and You” series features Dr. Preston Sprenkle, Associate Professor of Urology at Yale University, and Robert Palmer, a marketing executive and prostate cancer survivor. In this conversation with host Jordan Rich, Bob Palmer discusses his experience of incision-free ablation intervention as a cancer treatment. Here is a link to more details about Bob’s choice of ablation therapy using the TULSA Procedure: https://www.houstoniamag.com/sponsored/2024/04/pro-gives-men-with-prostate-disease-a-new-lease-on-life Thanks to Bob Palmer for sharing his story on this podcast, sponsored in part by Profound Medical. Learn more about Profound Medical and TULSA-PRO at https://profoundmedical.com/new-tulsa/.
    Afficher plus Afficher moins
    16 min